A potential reason for this association is that within the CNS, insulin is able to modulate many processes disrupted in PD, including autophagy, oxidative stress, and α-syn aggregation [83,84], mainly via the activation of the MAPK/ERK and PI3K/AKT pathways. This evidence concerns the gene AKT1 and Parkinson disease.